Moreover, TAK-580 also potently inhibited newly diagnosed MM and relapsed/refractory MM (RRMM) cells from patients (Figure 1C), without affecting normal donor peripheral blood B lymphocytes and cord blood CD34-positive cells (Figure 1D). The gene discussed is CD34; the disease is Miyoshi myopathy.